The Technical Analyst
Select Language :
Blueprint Medicines Corp [BPMC]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Blueprint Medicines Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Blueprint Medicines Corp is listed at the  Exchange

-0.36% $94.45

America/New_York / 28 mar 2024 @ 10:23


Blueprint Medicines Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 5 783.39 mill
EPS: -8.37
P/E: -11.28
Earnings Date: May 01, 2024
SharesOutstanding: 61.23 mill
Avg Daily Volume: 0.815 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -11.28 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.92x
Company: PE -11.28 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 89.96 - 98.94

( +/- 4.76%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-07 Albers Jeffrey W. Sell 11 033 Common Stock
2024-03-20 Albers Jeffrey W. Buy 10 000 Common Stock
2024-03-20 Albers Jeffrey W. Sell 2 730 Common Stock
2024-03-20 Albers Jeffrey W. Sell 6 251 Common Stock
2024-03-20 Albers Jeffrey W. Buy 15 073 Common Stock
INSIDER POWER
37.01
Last 100 transactions
Buy: 592 922 | Sell: 279 297

Forecast: 12:02 - $94.59

Live Trading Signals (every 1 min)

Forecast 1: 10:32 - $94.48
Forecast 2: 11:22 - $94.29
Forecast 3: 12:02 - $94.59
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $94.45 (-0.36% )
Volume 0.0353 mill
Avg. Vol. 0.815 mill
% of Avg. Vol 4.34 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Blueprint Medicines Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Blueprint Medicines Corp

RSI

Intraday RSI14 chart for Blueprint Medicines Corp

Last 10 Buy & Sell Signals For BPMC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:36buy$73.76N/AActive
Profile picture for
            Blueprint Medicines Corp

BPMC

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
REGNMar 28 - 10:21$960.00
GASUSDMar 28 - 10:19$6.98
WEMIXUSDMar 28 - 10:18$2.25
UNFIUSDMar 28 - 10:187.39
VERAMar 28 - 10:18$42.87
OPUSDMar 28 - 10:173.69
BELUSDMar 28 - 10:160.959
COOMar 28 - 10:17$101.34
AKTUSDMar 28 - 10:16$5.24
API3USDMar 28 - 10:153.78

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.